In June 2019, online pharmacy Valisure discovered N-nitrosodimethylamine (NDMA), a cancer-causing substance, in samples of Zantac. The company alerted the U.S. Food and Drug Administration
We are pleased to announce that Founding Partner Roopal Luhana will speak at MTMP Virtual Vegas, scheduled for Oct. 14-15, 2020. Luhana, a member of
The U.S. Food and Drug Administration (the “FDA”) announced today that it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the
By Eric Chaffin & Roopal Luhana The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD) estimates that 60 to 70 million people are
Zantac and generic ranitidine medications—used to treat heartburn, ulcers, gastroesophageal reflux disease (GERD), and general indigestion and stomach upset—have been the subject of several recalls
On September 26, 2019, five plaintiffs jointly filed a class-action lawsuit against Sanofi-Aventis LLC, makers of the stomach-acid medication, Zantac (ranitidine). They’ve also named as
Warfarin sodium (Coumadin or Marevan) is the most widely used anticoagulant in the United States. This medication is vital for patients with venous thromboembolism, chronic
In February 2019, the FDA issued a “black box warning” – the agency’s strongest and most prominent advisory — for Takeda’s popular gout drug, Uloric.
Designed to treat rheumatoid arthritis and ulcerative colitis, Pfizer’s Xeljanz (tofacitinib) has been linked with potentially deadly side effects, which include: Liver enzyme elevations, lipid
There is an old saying that sometimes the cure is worse than the disease. While medications are prescribed to treat ailments, sometimes the side effects
Uloric (also known as febuxostat), a gout medication, has been a “hot topic” in headlines recently due to an announcement by the U.S. Food and
Rheumatologists have a few pharmaceutical options for patients who are suffering from the effects of rheumatoid arthritis. One of those options is tofacitinib citrate, which
The FDA recently determined that Takeda Pharmaceutical’s medication, Uloric (febuxostat), should no longer be recommended as a first-line treatment for gout, a type of arthritis.
According to a recent announcement from Xeljanz manufacturer Pfizer, the company has taken steps to transition patients with rheumatoid arthritis (RA) who are taking the
One of the two key dangerous side effects at issue in pending and potential TDF lawsuits is loss of bone mineral density. Patients who have
The FDA first approved gout medication Uloric (febuxostat) in 2009, but under one condition: the manufacturer, Takeda, had to agree to conduct a large postmarket
At the heart of the TDF lawsuits filed against Gilead Pharmaceuticals is whether the manufacturer failed to properly warn doctors and patients of the HIV
A new study published in the scientific journal Rheumatology indicates that certain patients with rheumatoid arthritis (RA) who take Actemra (tocilizumab) to treat their symptoms
All federal testosterone replacement lawsuits were consolidated into one court in the Northern District of Illinois in June 2014. However, new research calls into question